ATRC AtriCure delivers big Q4 2025 earnings upside shares rise 379 percent on upbeat investor reaction TERN Terns Pharmaceuticals posts narrower than expected Q4 2025 loss shares post marginal gain in todays trading How Generate Biomedicines GENB is solving the problems its peers cannot 078 20260506 What Apellis APLS is doing to protect its market share Flirts with Support 20260508